Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 18, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

[Retroperitoneal extraskeletal myxoid chondrosarcoma].

A Fornari1

  • 1Dipartimento di Scienze Biomediche ed Oncologia Umana, Università di Torino, Italy.

Pathologica
|December 21, 2006
PubMed
Summary

Extraskeletal myxoid chondrosarcoma, a rare soft tissue tumor, was identified in a kidney tumor. This case highlights the tumor's varied presentation and expression of neural markers.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.

European journal of neurology·2018
Same author

Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment.

Clinical radiology·2016
Same author

Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

Clinical radiology·2016
Same author

Supratracheal laryngectomy: current indications and contraindications.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2015
Same author

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

Leukemia·2007
Same author

[Immunohistochemistry in thyroid needle aspiration samples].

Pathologica·2006

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue tumor with controversial immunophenotype.
  • The specific translocation t(9;22)(q22;q12) is highly characteristic of EMC.
  • EMC is often grouped with tumors of uncertain differentiation due to infrequent well-formed cartilage.

Observation:

  • A 75-year-old female presented with a large kidney tumor with extrarenal extension.
  • The tumor was located in the perirenal fat tissue.
  • Histological examination revealed a malignant mesenchymal tumor with myxoid and chondroid differentiation.

Findings:

  • The diagnosis of extraskeletal myxoid chondrosarcoma was confirmed.
  • The tumor showed focal positivity for NSE (neuron-specific enolase) via immunohistochemistry.
  • This case presented a rare tumor location and extensive chondroid differentiation.

Implications:

  • The findings contribute to understanding the diverse presentation of EMC.
  • Immunohistochemical results support the expression of neural markers in EMC.
  • This case underscores the importance of considering EMC in the differential diagnosis of soft tissue tumors.

Related Experiment Videos

Last Updated: Jul 18, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019